NBO Pharma Inc., 2026-11-09
A new SEC Form D private-offering notice from Bedford, NY, a $7,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage pharma developing an intranasal octreotide spray for idiopathic intracranial hypertension, a condition with no approved drugs.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR sourceThe Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.